Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Cirino

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
Inflammation & Allergy Drug Targets|February 1, 2011
Hydrogen sulphide in heart and systemic circulationMariarosaria Bucci, Giuseppe Cirino
British Journal of Pharmacology|July 1, 2020
The many mechanisms of action of Chloroquine: to use or not to use (in COVID-19) that is the questionGiuseppe Cirino, Amrita Ahluwalia
Current Opinion in Pharmacology|June 17, 2006
Proteinase-activated receptors (PARs): crossroads between innate immunity and coagulationGiuseppe Cirino, Nathalie Vergnolle
British Journal of Pharmacology|October 29, 2017
Targeting inflammation to reduce cardiovascular disease riskPasquale Maffia, Giuseppe Cirino
British Journal of Pharmacology|June 16, 2018
Launch of mini-reviews in hot topicsAmrita Ahluwalia, Giuseppe Cirino
Expert Opinion on Therapeutic Patents|May 11, 2010
Thrombin receptors and their antagonists: an update on the patent literatureGiuseppe Cirino, Beatrice Severino
Current Pharmaceutical Design|January 29, 2002
The nitric oxide related therapeutic phenomenon: a challenging taskGiuseppe Cirino, Vincenzo Santagada, Giuseppe Caliendo
British Journal of Pharmacology|June 10, 2014
Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginnersAndreas Papapetropoulos, Matthew Whiteman, Giuseppe Cirino
Physiological Reviews|April 18, 2022
Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organsGiuseppe Cirino, Csaba Szabo, Andreas Papapetropoulos
Vascular Pharmacology|September 27, 2005
Protease-activated receptor-2 (PAR2) in cardiovascular systemMariarosaria Bucci, Fiorentina Roviezzo, Giuseppe Cirino
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
Inflammation & Allergy Drug Targets|February 1, 2011
Hydrogen sulphide in heart and systemic circulationMariarosaria Bucci, Giuseppe Cirino
British Journal of Pharmacology|July 1, 2020
The many mechanisms of action of Chloroquine: to use or not to use (in COVID-19) that is the questionGiuseppe Cirino, Amrita Ahluwalia
Current Opinion in Pharmacology|June 17, 2006
Proteinase-activated receptors (PARs): crossroads between innate immunity and coagulationGiuseppe Cirino, Nathalie Vergnolle
British Journal of Pharmacology|October 29, 2017
Targeting inflammation to reduce cardiovascular disease riskPasquale Maffia, Giuseppe Cirino
British Journal of Pharmacology|June 16, 2018
Launch of mini-reviews in hot topicsAmrita Ahluwalia, Giuseppe Cirino
Expert Opinion on Therapeutic Patents|May 11, 2010
Thrombin receptors and their antagonists: an update on the patent literatureGiuseppe Cirino, Beatrice Severino
Current Pharmaceutical Design|January 29, 2002
The nitric oxide related therapeutic phenomenon: a challenging taskGiuseppe Cirino, Vincenzo Santagada, Giuseppe Caliendo
British Journal of Pharmacology|June 10, 2014
Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginnersAndreas Papapetropoulos, Matthew Whiteman, Giuseppe Cirino
Physiological Reviews|April 18, 2022
Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organsGiuseppe Cirino, Csaba Szabo, Andreas Papapetropoulos
Vascular Pharmacology|September 27, 2005
Protease-activated receptor-2 (PAR2) in cardiovascular systemMariarosaria Bucci, Fiorentina Roviezzo, Giuseppe Cirino
Pageof 20